Janet Liang Sells 10,360 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) insider Janet Liang sold 10,360 shares of the business’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $325,822.00. Following the transaction, the insider owned 248,697 shares in the company, valued at $7,821,520.65. The trade was a 4.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Price Performance

OSCR stock traded up $0.65 during mid-day trading on Tuesday, reaching $32.90. The company’s stock had a trading volume of 4,754,751 shares, compared to its average volume of 7,062,275. The stock has a market cap of $10.15 billion, a PE ratio of 23.50, a P/E/G ratio of 0.66 and a beta of 2.37. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $33.55. The company’s 50 day moving average is $30.49 and its two-hundred day moving average is $22.87.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The business’s revenue was up 70.4% on a year-over-year basis. During the same period last year, the company posted ($0.89) EPS. Equities research analysts expect that Oscar Health, Inc. will post 1.54 EPS for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on OSCR. Piper Sandler reissued an “overweight” rating and set a $36.00 price objective on shares of Oscar Health in a research note on Tuesday, July 28th. Wells Fargo & Company raised their target price on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 13th. Barclays lifted their price target on Oscar Health from $35.00 to $39.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Zacks Research raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Finally, UBS Group upped their price objective on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Oscar Health presently has an average rating of “Hold” and an average target price of $26.22.

Institutional Investors Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OSCR. Geode Capital Management LLC raised its stake in shares of Oscar Health by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock valued at $68,964,000 after acquiring an additional 116,430 shares during the period. BIT Capital GmbH boosted its stake in shares of Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after buying an additional 5,227,152 shares during the period. Simplify Asset Management Inc. acquired a new position in Oscar Health during the 4th quarter worth approximately $2,948,000. Fortis Group Advisors LLC raised its holdings in shares of Oscar Health by 82.9% in the 4th quarter. Fortis Group Advisors LLC now owns 189,857 shares of the company’s stock valued at $2,724,000 after purchasing an additional 86,035 shares in the last quarter. Finally, Convergence Investment Partners LLC purchased a new stake in shares of Oscar Health during the 1st quarter worth $1,208,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.